Eric Klasen
Manager of Obelis Swiss
Life Sciences expert in Regulatory Affairs and Quality Assurance systems with focus on solutions underpinning Healthcare strategies and Business objectives.
Member of the Board of Directors and Treasurer of the European Forum of Good Clinical Practice, Belgium. Member of the Board of Directors of SimpliNext, Switzerland. Member of the Supervisory Board of DIABETER, a group of Diabetes clinics in the Netherlands, and chair of the Supervisory Board of NOK/Best Care Foundation, a group of Obesity Clinics in the Netherlands.
From July 2004 – May 2019, he was Vice President EMEA Regulatory Affairs & Quality at Medtronic International Trading, Switzerland, and founder and President of Medtronic BioPharma Europe. He retired from Medtronic in May 2019.
Prior to Medtronic, he held the following positions:
- 1998-2004, Head of Global Drug Regulatory Affairs at Novartis Consumer Health, Switzerland (currently GSK Consumer Healthcare).
- 1994-1998, Director Regulatory Compliance, Quality Assurance and Quality Control at Chiron Vaccines (currently GSK Vaccines), Italy.
- 1986-1994, Director R&D at Serono Diagnostics, Italy, Director Operations Technical Support at IFS (Istituto Farmacologico Serono), Italy, and Director of QA/QC at Serono Biotech, Switzerland (currently Merck–Serono).
- 1982-1986, Head of the Immunochemistry Department at TNO Medical Biological Laboratory, Netherlands.
- 1977-1982, Researcher at the Dept of Human Genetics of the University of Leiden, Netherlands.
He obtained a BSc. degree (1975) in Biochemistry and an MSc. degree (1977) in Biochemistry & Genetics from the University of Leiden, Netherlands.